Inovio Pharmaceuticals, Inc. (INO)
1.435
-0.02
(-1.71%)
USD |
NASDAQ |
Nov 13, 16:00
1.42
-0.02
(-1.05%)
After-Hours: 19:59
Inovio Pharmaceuticals Shareholders Equity (Quarterly) : -33.92M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -33.92M |
| June 30, 2026 | 4.371M |
| March 31, 2026 | 6.068M |
| December 31, 2025 | 24.10M |
| September 30, 2025 | -7.72M |
| June 30, 2025 | 28.53M |
| March 31, 2025 | 51.25M |
| December 31, 2024 | 68.50M |
| September 30, 2024 | 73.54M |
| June 30, 2024 | 96.74M |
| March 31, 2024 | 94.44M |
| December 31, 2023 | 117.35M |
| September 30, 2023 | 138.16M |
| June 30, 2023 | 169.37M |
| March 31, 2023 | 199.21M |
| December 31, 2022 | 222.36M |
| September 30, 2022 | 266.70M |
| June 30, 2022 | 297.67M |
| March 31, 2022 | 355.08M |
| December 31, 2021 | 399.67M |
| September 30, 2021 | 453.57M |
| June 30, 2021 | 508.55M |
| March 31, 2021 | 581.61M |
| December 31, 2020 | 461.14M |
| September 30, 2020 | 323.90M |
| Date | Value |
|---|---|
| June 30, 2020 | 186.26M |
| March 31, 2020 | 184.32M |
| December 31, 2019 | 3.435M |
| September 30, 2019 | 33.69M |
| June 30, 2019 | 53.62M |
| March 31, 2019 | 77.91M |
| December 31, 2018 | 86.94M |
| September 30, 2018 | 103.61M |
| June 30, 2018 | 111.40M |
| March 31, 2018 | 113.00M |
| December 31, 2017 | 142.39M |
| September 30, 2017 | 162.02M |
| June 30, 2017 | 123.43M |
| March 31, 2017 | 105.85M |
| December 31, 2016 | 123.28M |
| September 30, 2016 | 146.88M |
| June 30, 2016 | 161.99M |
| March 31, 2016 | 170.97M |
| December 31, 2015 | 175.69M |
| September 30, 2015 | 193.14M |
| June 30, 2015 | 180.56M |
| March 31, 2015 | 103.12M |
| December 31, 2014 | 111.23M |
| September 30, 2014 | 116.73M |
| June 30, 2014 | 121.84M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Precigen, Inc. | 83.79M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Ionis Pharmaceuticals, Inc. | 393.64M |
| Nektar Therapeutics | 903.12M |
| Rigel Pharmaceuticals, Inc. | 445.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 60.14M |
| Total Liabilities (Quarterly) | 94.06M |
| Debt to Equity Ratio | -0.2147 |
| Current Ratio | 0.575 |
| Net Debt Paydown Yield | 0.50% |